Cargando…
Assessment of Cardiac Remodeling—A Chance for Novel Cardiac Biomarkers?
Autores principales: | Jirak, Peter, Mirna, Moritz, Wernly, Bernhard, Paar, Vera, Hoppe, Uta C., Lichtenauer, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408733/ https://www.ncbi.nlm.nih.gov/pubmed/32635167 http://dx.doi.org/10.3390/jcm9072087 |
Ejemplares similares
-
Influences of Ivabradine treatment on serum levels of cardiac biomarkers sST2, GDF-15, suPAR and H-FABP in patients with chronic heart failure
por: Jirak, Peter, et al.
Publicado: (2017) -
Expression of the Novel Cardiac Biomarkers sST2, GDF-15, suPAR, and H-FABP in HFpEF Patients Compared to ICM, DCM, and Controls
por: Jirak, Peter, et al.
Publicado: (2020) -
Autoimmune myocarditis is not associated with left ventricular systolic dysfunction
por: Mirna, Moritz, et al.
Publicado: (2019) -
Cell-Free Double-Stranded DNA to DNase Ratio Predicts Outcome after Primary Survived Cardiac Arrest
por: Rezar, Richard, et al.
Publicado: (2022) -
Carcinoid heart disease involving the left heart: a case report and biomarker analysis
por: Lichtenauer, Michael, et al.
Publicado: (2019)